Spongiotic dermatitis describes skin inflammation that causes swelling, redness, and itching. It's most often associated with atopic dermatitis or eczema.

In a meta-analysis of 42 studies, exposure to air pollutants and high temperatures was associated with higher risk for clinic ...

According to a recent meta-analysis published in eClinicalMedicine, antibiotic use during pregnancy or in early childhood ...

Rezpegaldesleukin, an investigational interleukin-pathway agonist, demonstrated efficacy and safety for people with moderate ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

NKTR stock is up around 150% in today’s trading session following the recently announced positive results from its Phase 2b ...

Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a ...

Nektar Therapeutics NKTR announced that the phase IIb REZOLVE-AD study evaluating its lead pipeline candidate, ...

This new meta-analysis looked to better solidify connections between atopic dermatitis and environmental irritants, such as ...

USA: Researchers have discovered in a new study that young children with moderate-to-severe atopic dermatitis (AD) tend to be ...

Learn how Dupixent helps diverse eczema patients and why inclusive clinical trials are vital for fair healthcare.

Shares of Nektar Therapeutics soared after the company said it would release topline data from a study of its atopic dermatitis treatment rezpegaldesleukin. The stock was up 31% at $12.49 in Monday's ...